Back
Speaker illustration

undefined undefined undefined

Sessions Presentations Events Articles

Biomarkers in acute coronary syndromes (3)

Event: ESC Congress 2025

Topic: Biomarkers

Session type: Moderated ePosters

Access
Like
Thumbnail

Pharmacotherapy in acute coronary syndromes (1)

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session type: Moderated ePosters

Access
Like
Thumbnail

New avenues for combating atherothrombosis

Event: EuroThrombosis and EuroVessels 2022

Topic: Thrombosis, Bleeding

Session type: Teaching Course

Access
Like
Thumbnail

Antithrombotic and anticoagulant therapy

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session type: Moderated ePosters

Access
Like
Thumbnail

Guidelines in Practice: dual antiplatelet therapy (DAPT): a roller coaster ride

Event: ESC Congress 2022

Topic: Treatment

Session type: Guidelines in Practice

Access
Like
Thumbnail

Antithrombotic therapy in patients with acute coronary syndromes

Event: ESC Congress 2019

Topic: Treatment

Session type: Symposium

Access
Like
Thumbnail

Optimising non-vitamin K antagonist oral anticoagulant (NOAC) management in atrial fibrillation and acute coronary syndrome (ACS)/percutaneous coronary intervention (PCI) - Clinical practice perspective

Event: ESC Congress 2019

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium - Experts on the Spot

Access
Like
Thumbnail

Controversies in anti-platelet therapy

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session type: Debate Session

Access
Like
Thumbnail

Dual antiplatelet therapy and PCI - Important controversies

Event: ESC Congress 2018

Topic: Antiplatelet Agents

Session type: Debate Session

Access
Like
Thumbnail

Great Debate on STEMI: current controversies on immediate treatment.

Event: Acute Cardiovascular Care 2018

Topic: Miscellaneous

Session type: Debate Session

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources